Screener
Cytokinetics CYTK Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's current debt?
- Cytokinetics (CYTK) reported current debt of $27.36M in Q2 2026.
- How has Cytokinetics's current debt changed year-over-year?
- Cytokinetics's current debt increased by 90.0% year-over-year, from $14.4M to $27.36M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Cytokinetics's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude